The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 141, Issue , 1996, Pages 183-192

  Miyamoto, C T ^a   Brady, L W ^a   Rackover, M A ^a   Emrich, J ^a   Class, R ^a   Bender, H ^a   Micaily, B ^a   Steplewski, Z ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

ADJUVANT THERAPY; ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CLINICAL TRIAL; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; ANTIBODIES, MONOCLONAL; ASTROCYTOMA; BRAIN NEOPLASMS; GLIOBLASTOMA; GLIOMA; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOIMMUNOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE;

MLCS; MLOWN;

EID: 0029718895     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-79952-5_13     Document Type: Article

References (0)